A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

August 31, 2011

Conditions
Moderate and Severe Plaque Psoriasis
Interventions
DRUG

Placebo

DRUG

AEB071

Trial Locations (40)

23507

Virginia Clinical Research, Norfolk

29607

Palmetto Clinical Trial Services, Greenville

33781

Belleair Research Center, LLC, Pinellas Park

40202

Dermatology Specialists, Louisville

63117

Central Dermatology, St Louis

66215

Kansas City Dermatology, PA, Overland Park

71913

Burke Pharmaceutical Research, Hot Springs

77030

Center for Clinical Studies, Houston

77056

Suzanne Bruce & Associates, PA, Houston

02114

Massachusetts General Hospital, Boston

Unknown

Novartis Investigative site, Buenos Aires

Novartis Investigative site, Mendoza

Novartis Investigative site, Benowa

Novartis Investigative site, Carlton

Novartis Investigative site, Kogarah

Novartis Investigative site, Parkville

Novartis Investigative site, Brussels

Novartis Investigative site, Edegem

Novartis Investigative site, Liège

Novartis Investigative site, Berlin

Novartis Investigative site, Bonn

Novartis Investigative site, Erlangen

Novartis Investigative site, Frankfurt

Novartis Investigative site, Hamburg

Novartis Investigative site, Kiel

Novartis Investigative site, Leipzig

Novartis Investigative site, Regensburg

Novartis Investigative Site, Guatemala City

Novartis Investigative site, Milan

Novartis Investigative Site, Modena

Novartis Investigative Site, Rome

Novartis Investigative Site, Siena

Novartis Investigative Site, Verona

Novartis Investigative Site, Ankara

Novartis Investigative Site, Gaziantep

Novartis Investigative Site, Izmir

Novartis Investigative Site, Manisa

Novartis Investigative site, Nuneaton

Novartis Investigative site, Salford

Novartis Investigative site, Southampton

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY